Westerly Capital Management sold 2,700,000 Lumen Technologies shares; estimated trade size $22.22 million (based on quarterly average pricing). The quarter-end Lumen position value decreased by $15.20 ...

The Magnificent Seven stocks have returned 876% over the past 10 years. In comparison, the S&P 500 has only returned 235% over that same stretch. Could an investment in this Roundhill ETF set you up ...

Micron and Applied Materials will partner to accelerate the semiconductor technology pipeline. The move comes as Micron is seeing surging demand for its memory processors. Micron's memory chips are a ...

CoreWeave has a backlog of more than $66 billion. For 2026, management expects revenue of between $12 billion and $13 billion. The stock pulled back sharply around the end of February, dropping by 24% ...

Uber and Airbnb both benefit from powerful brand recognition and network effects. These businesses both post double-digit revenue growth and are consistently profitable. The market isn’t asking ...

Nvidia, AMD, and Broadcom are the top chipmakers behind the AI chip boom. Micron is benefiting from a surge in HBM demand related to the AI infrastructure buildout. As the main manufacturer of AI ...

That type of volatility is reflected in Hecla Mining's share price performance in 2026, but investors need to consider a couple of things about the stock: The company is likely to be even more of a ...

An industry with enduring demand is hiding in plain sight. It's simply not exciting enough for most investors. Just wait.

Figma, The Trade Desk, and Duolingo have fallen by at least 70% since peaking last year. Figma saw revenue growth accelerate in its latest quarter. The Trade Desk and Duolingo are now trading for less ...

Garden Investment added 102,903 shares of The Middleby Corporation, an estimated trade size of $13.5 million. The firm's stake of 3,379,737 shares represents a more than 6% stake in Middleby. The ...

Let's consider two under-the-radar stocks that are worth serious consideration for long-term investors: Axsome Therapeutics ( AXSM +1.88%) and Madrigal Pharmaceuticals ( MDGL +1.22%).

The beverage giant's organic revenue continues to climb, and a robust dividend provides a compelling income stream for investors.